Stella M. Davies

28.3k total citations · 5 hit papers
518 papers, 18.0k citations indexed

About

Stella M. Davies is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Stella M. Davies has authored 518 papers receiving a total of 18.0k indexed citations (citations by other indexed papers that have themselves been cited), including 217 papers in Hematology, 125 papers in Public Health, Environmental and Occupational Health and 124 papers in Immunology. Recurrent topics in Stella M. Davies's work include Hematopoietic Stem Cell Transplantation (169 papers), Acute Lymphoblastic Leukemia research (109 papers) and Childhood Cancer Survivors' Quality of Life (74 papers). Stella M. Davies is often cited by papers focused on Hematopoietic Stem Cell Transplantation (169 papers), Acute Lymphoblastic Leukemia research (109 papers) and Childhood Cancer Survivors' Quality of Life (74 papers). Stella M. Davies collaborates with scholars based in United States, United Kingdom and Canada. Stella M. Davies's co-authors include Sonata Jodele, Daniel J. Weisdorf, John E. Wagner, Todd E. DeFor, Kasiani C. Myers, Leslie L. Robison, Julie A. Ross, Benjamin L. Laskin, Christopher E. Dandoy and Jens Goebel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Stella M. Davies

482 papers receiving 17.7k citations

Hit Papers

Transplantation of unrelated donor umbilical cord blood i... 2001 2026 2009 2017 2002 2001 2009 2014 2014 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival
    2002 743 citations John E. Wagner, Todd E. DeFor et al. Blood profile →
  2. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
    2001 522 citations Stella M. Davies, Daniel J. Weisdorf et al. Blood profile →
  3. The Childhood Cancer Survivor Study: A National Cancer Institute–Supported Resource for Outcome and Intervention Research
    2009 506 citations Stella M. Davies et al. Journal of Clinical Oncology profile →
  4. Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
    2014 313 citations Alan S. Gamis, Todd A. Alonzo et al. Journal of Clinical Oncology profile →
  5. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031
    2014 304 citations Kirk R. Schultz, Andrew J. Carroll et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stella M. Davies United States 64 8.7k 5.0k 4.3k 3.6k 3.4k 518 18.0k
Stephanie J. Lee United States 85 15.8k 1.8× 5.9k 1.2× 6.8k 1.6× 5.7k 1.6× 4.0k 1.2× 629 26.1k
Jakob Passweg Switzerland 72 13.3k 1.5× 4.7k 0.9× 2.7k 0.6× 6.1k 1.7× 1.6k 0.5× 497 21.0k
Joseph H. Antin United States 90 17.8k 2.0× 9.5k 1.9× 4.2k 1.0× 6.4k 1.8× 2.1k 0.6× 491 28.0k
Mohamad Mohty France 82 18.6k 2.1× 6.4k 1.3× 5.9k 1.4× 7.6k 2.1× 1.6k 0.5× 928 26.0k
Robert J. Soiffer United States 89 15.0k 1.7× 10.6k 2.1× 3.3k 0.8× 7.1k 2.0× 1.4k 0.4× 506 25.4k
Aloïs Gratwohl Switzerland 80 17.1k 2.0× 5.7k 1.1× 4.4k 1.0× 4.7k 1.3× 1.3k 0.4× 515 23.8k
Claudio Anasetti United States 89 20.3k 2.3× 11.9k 2.4× 4.7k 1.1× 5.5k 1.5× 1.8k 0.5× 459 27.7k
Robert Peter Gale United States 78 14.5k 1.7× 5.3k 1.1× 3.9k 0.9× 5.6k 1.5× 1.3k 0.4× 609 24.0k
Ernst Holler Germany 63 9.3k 1.1× 6.6k 1.3× 1.5k 0.3× 3.1k 0.9× 911 0.3× 370 16.6k
Gerhard Ehninger Germany 78 13.6k 1.6× 4.3k 0.9× 3.8k 0.9× 6.5k 1.8× 1.0k 0.3× 678 25.0k

Countries citing papers authored by Stella M. Davies

Since Specialization
Citations

This map shows the geographic impact of Stella M. Davies's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stella M. Davies with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stella M. Davies more than expected).

Fields of papers citing papers by Stella M. Davies

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stella M. Davies. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stella M. Davies. The network helps show where Stella M. Davies may publish in the future.

Co-authorship network of co-authors of Stella M. Davies

This figure shows the co-authorship network connecting the top 25 collaborators of Stella M. Davies. A scholar is included among the top collaborators of Stella M. Davies based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stella M. Davies. Stella M. Davies is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luebbering, Nathan, Kelly E. Lake, Adam Lane, et al.. (2025). Kinetics of DNases after hematopoietic stem cell transplant. PubMed. 2(2). 100055–100055.
2.
3.
4.
Myers, Kasiani C., Stella M. Davies, Carolyn Lutzko, et al.. (2025). Clinical Use of ZSCAN4 for Telomere Elongation in Hematopoietic Stem Cells. NEJM Evidence. 4(3). EVIDoa2400252–EVIDoa2400252.
5.
Luebbering, Nathan, Kasiani C. Myers, Anthony Sabulski, et al.. (2025). Oxidative Stress Early After Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 31(3). 135.e1–135.e10. 3 indexed citations
6.
Vicente-Muñoz, Sara, Suzanne Summer, Khyati Y. Mehta, et al.. (2025). Metabolic reprogramming in Fanconi anemia: Evidence of compromised glucose oxidation, enhanced ketogenesis, and metabolic inflexibility. Science Advances. 11(48). eady6117–eady6117.
7.
Auletta, Jeffery J., Jennifer Holter‐Chakrabarty, Pashna N. Munshi, et al.. (2024). Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplantation and Cellular Therapy. 30(12). 1124–1138. 2 indexed citations
8.
Lane, Adam, et al.. (2024). Liver abnormalities are frequent and persistent in patients with Fanconi anemia. Blood Advances. 8(6). 1427–1438. 1 indexed citations
9.
Dexheimer, Judith W., et al.. (2020). Initial steps to measurement and improvement of family-centered communication during the pediatric patient journey of bone marrow transplantation. Knowledge Management & E-Learning An International Journal. 488–504. 1 indexed citations
10.
Opoka, Amy M., Lin Fei, Huaiyu Zang, et al.. (2020). Longitudinal characterization of olfactomedin-4 expressing neutrophils in pediatric patients undergoing bone marrow transplantation. PLoS ONE. 15(5). e0233738–e0233738. 6 indexed citations
11.
Phillips, Christine L., Adam Lane, Robert B. Gerbing, et al.. (2020). Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology Group. Clinical Cancer Research. 26(12). 2891–2897. 4 indexed citations
12.
Gloude, Nicholas J., Pooja Khandelwal, Nathan Luebbering, et al.. (2017). Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD. Blood. 130(10). 1259–1266. 82 indexed citations
13.
Gloude, Nicholas J., Sonata Jodele, Ashley Teusink‐Cross, et al.. (2017). Combination of High-Dose Methylprednisolone and Defibrotide for Veno-Occlusive Disease in Pediatric Hematopoietic Stem Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 24(1). 91–95. 8 indexed citations
14.
Jodele, Sonata, Kejian Zhang, Fanggeng Zou, et al.. (2015). The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy. Blood. 127(8). 989–996. 138 indexed citations
15.
Li, Xiaoli, Liang Li, Jie Li, et al.. (2014). Concomitant Inactivation of Foxo3a and Fancc or Fancd2 Reveals a Two-Tier Protection from Oxidative Stress-Induced Hydrocephalus. Antioxidants and Redox Signaling. 21(12). 1675–1692. 6 indexed citations
16.
Gamis, Alan S., Todd A. Alonzo, Soheil Meshinchi, et al.. (2014). Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531. Journal of Clinical Oncology. 32(27). 3021–3032. 313 indexed citations breakdown →
17.
Sakagami, Takuro, David Beck, Kanji Uchida, et al.. (2010). Patient-derived Granulocyte/Macrophage Colony–Stimulating Factor Autoantibodies Reproduce Pulmonary Alveolar Proteinosis in Nonhuman Primates. American Journal of Respiratory and Critical Care Medicine. 182(1). 49–61. 67 indexed citations
18.
Schultz, Kirk R., W. Paul Bowman, Alexander Aledo, et al.. (2009). Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study. Journal of Clinical Oncology. 27(31). 5175–5181. 436 indexed citations
19.
MacMillan, Margaret L., Daniel J. Weisdorf, John E. Wagner, et al.. (2002). Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems. Biology of Blood and Marrow Transplantation. 8(7). 387–394. 297 indexed citations
20.
Perentesis, John P., et al.. (1997). Granulocyte-Macrophage colony-Stimulating factor receptor-Targeted therapy of chemotherapy- and radiation-Resistant human myeloid leukemias. Leukemia & lymphoma. 25(3-4). 247–256. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanie J. Lee Breakdown of academic impact, for papers by Jakob Passweg Breakdown of academic impact, for papers by Joseph H. Antin Breakdown of academic impact, for papers by Mohamad Mohty Breakdown of academic impact, for papers by Robert J. Soiffer Breakdown of academic impact, for papers by Aloïs Gratwohl Breakdown of academic impact, for papers by Claudio Anasetti Breakdown of academic impact, for papers by Robert Peter Gale Breakdown of academic impact, for papers by Ernst Holler Breakdown of academic impact, for papers by Gerhard Ehninger
Rankless by CCL
2026